The European Commission approves fully liquid presentation of GSK's meningococcal vaccine, Menveo, to protect against ...

GSK said on Friday that its respiratory syncytial virus (RSV) vaccine has received approval in Japan for expanded use in ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js ...

GSK (GSK) announced that the European Commission, EC, has approved a single-vial, fully liquid presentation of Menveo to help protect against ...

Pitcairn Co. cut its holdings in GSK plc (NYSE:GSK – Free Report) by 14.1% during the 3rd quarter, according to its most ...

GSK PLC GSK shares inched down 0.63% to £13.38 Tuesday, on what proved to be an all-around poor trading session for the stock ...

The European Commission (EC) has approved a single-vial, fully liquid presentation of Menveo (meningococcal Group A, C, W-135 ...

GSK's liquid meningitis vaccine Menveo has been approved by EU regulators, paving the way for a simpler vaccination process ...

British drugmaker GSK said on Tuesday its experimental therapy, linerixibat, met its main goal in a late-stage trial to treat ...

A phase 3 trial of GSK’s linerixibat in a liver disease has hit its primary endpoint, keeping the drugmaker on track to ...

The GSK share price has been in a strong freefall after peaking at 1,785p in September. Most recently, the GSK stock ...

A judge in the U.K. last month sided with Pfizer over GSK in a respiratory syncytial virus vaccine patent lawsuit, ...